US and Iran Near Nuclear Deal as Ceasefire Extension Awaits Trump Approval 
Baltic Drone Incidents Raise NATO Security Concerns 
US-Iran Ceasefire Extension Near as Strait of Hormuz Shipping Deal Advances 
U.S. Lawmakers Back Ukraine’s Request for More Patriot Missiles Amid Rising Russian Attacks 
Zelenskiy Urges Trump for More Patriot Missiles as Russia Intensifies Ballistic Attacks 
US Imposes Fresh Iran Oil Sanctions Despite Progress on Ceasefire Talks 
Kentucky School District Secures $27 Million in Social Media Addiction Lawsuit Settlements 
Canada and Germany Advance Major LNG Supply Partnership 
US Tightens Ebola Controls as Congo Outbreak Sparks Global Concern 
US Designates Brazil’s PCC and Comando Vermelho as Global Terrorist Entities Ahead of FTO Listing 
UN Blacklists Israel and Russia Over Conflict-Related Sexual Violence Claims 
Trump Administration Threatens Newark Airport International Travel Shutdown Over Immigration Dispute 
U.S. Reinstates Sanctions on U.N. Expert Francesca Albanese Amid Legal Battle 
Netanyahu Orders Expansion of Israeli Control in Gaza to 70% 
Netanyahu Gaza Expansion Plan Sparks Hamas Condemnation and International Concern 
US Launches New Trade Investigation Into Vietnam Over Intellectual Property Concerns 
Russia Prepares New Large-Scale Attack on Ukraine, Zelenskiy Warns 
The White House is reportedly considering former Deputy Surgeon General Erica Schwartz as its next nominee to lead the Centers for Disease Control and Prevention, according to a source familiar with ongoing internal discussions. Schwartz, who held senior public health responsibilities during President Donald Trump's first term, played a central role in managing the federal government's COVID-19 response, with oversight spanning national preparedness and interagency coordination.
Her potential nomination comes amid a period of significant leadership instability at the CDC. Former Director Susan Monarez was dismissed last August after publicly opposing vaccine policy changes championed by Health and Human Services Secretary Robert F. Kennedy Jr. Following Monarez's departure, HHS Deputy Secretary Jim O'Neill stepped in as acting CDC director before Jay Bhattacharya — currently heading the National Institutes of Health — assumed the role in February. O'Neill has since transitioned to lead the National Science Foundation.
Schwartz's prospective appointment has drawn early praise from notable public health figures across the political spectrum. Brett Giroir, who served as assistant secretary of health under the first Trump administration, highlighted her strong character and commitment to public service. Demetre Daskalakis, a former senior CDC immunization official who stepped down last year over vaccine policy disputes, credited Schwartz with demonstrating effective leadership throughout the pandemic and praised her work strengthening preparedness within the commissioned corps.
Washington Post reporter Dan Diamond also noted that Texas health commissioner Jen Shuford and senior FDA official Sara Brenner are being considered for other high-level CDC positions. Daskalakis suggested the three could form a capable leadership team, provided they are given the autonomy to operate independently of political interference from the HHS secretary.
No formal announcement regarding Schwartz's nomination has been made at this time.
